# A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV

> **NCT03239496** · PHASE3 · COMPLETED · sponsor: **Fidec Corporation** · enrollment: 773 (actual)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** IPV
- **BIOLOGICAL:** f-IPV

## Key facts

- **NCT ID:** NCT03239496
- **Lead sponsor:** Fidec Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-23
- **Primary completion:** 2018-11-13
- **Final completion:** 2018-11-13
- **Target enrollment:** 773 (ACTUAL)
- **Last updated:** 2023-07-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03239496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03239496, "A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03239496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*